Connect Biopharma
IPOAspiring to Improve Patients' Lives
Connect Biopharma was founded in 2012, is headquartered in San Diego, United States, lists 51–200 employees, and has $215.2M in recorded funding across 4 rounds.
- Headquarters
- San Diego, California
- Employees
- 51–200
- Founded
- 2012
- Business Model
- B2B
- Website
- connectbiopharma.com
- Total Funding
- $215.2M
- Last Round
- $20.2M Corporate RoundMar 2026
- Rounds
- 4
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 4 funding rounds and 8 investors for this company. The full record is or through the API.
About
Connect Biopharma is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and COPD. Headquartered in San Diego, California, the Company is advancing rademikibart (CBP-201), a next-generation, potentially best-in-class monoclonal antibody designed to target interleukin-4 receptor alpha (IL-4Rα). Rademikibart is being evaluated in global Phase 2 clinical studies (Seabreeze STAT) for the treatment of acute exacerbations of asthma and COPD — conditions with significant unmet medical need. Founded in 2012 with operations in San Diego and China, Connect Biopharma trades on Nasdaq under the ticker CNTB. The company's scientific approach centers on next-generation biologics designed to redefine treatment landscapes for patients with serious inflammatory diseases.
Summary
Connect Biopharma is a Biotech company based in San Diego, United States, founded in 2012. It lists 51–200 employees. It has raised $215.2M in total across 4 rounds, most recently a $20.2M Corporate Round in Mar 2026. Investors include Qiming VP, Panacea Venture and Cowin Venture.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Mar 2026
Sign up to see all 5 events
Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/connect-biopharma"><img src="https://indexed.vc/api/badge/company/connect-biopharma" alt="Connect Biopharma on Indexed.vc" width="260" height="76" /></a>